Enhance your nephrology practice with CME and tools focused on kidney medicine.
Translating the Latest KDIGO Guidelines Into Practice: IV Iron Therapy in Patients With Non–Dialysis-Dependent CKD
Patrick Rossignol, MD, PhD
Julio Núñez, MD, PhD
The Podocyte Problem: Understanding FSGS
Kirk Campbell, MD
Alessia Fornoni, MD, PhD
Navigating KDIGO Practice Guideline Recommendations to Maximize Proteinuria Reduction in Patients With IgAN
Chee Kay Cheung, MBChB, PhD, FRCP
Claudia Seikrit, MD
Case-Based Approach: Managing Hyperkalemia in Patients With CKD and Heart Failure
Ellie Kelepouris, MD, FACP, FAHA
Nihar R. Desai, MD, MPH
Individualized Management of Hyperkalemia: The Role of Potassium Binders in Patients With Cardiorenal Disease
The Patient-Clinician Connection in Managing CKD-aP
James Burton, DM, FRCP
Lucio Manenti, MD, PhD
Kappa-Opioid Settings: Real-World Evidence Insights
Emilio Sanchez, MD, PhD
CKD-aP or Something Else? Decoding the Diagnosis
Stuck on Antihistamines for Managing Patients With CKD-aP? Time to Reconsider!
Antoine Lanot, MD, PhD
Gil Yosipovitch, MD
Inside the IgAN Clinic: Shared Decision-Making Into Practice
Jonathan Barratt, MD, PhD
Targeting CKD-aP at the Source: Key Mechanisms and Treatments
Steven Fishbane, MD
Maurizio Gallieni, MD
CKD-aP Treatment Tool Kit
Leonie Kraft, MD
Potassium Binders: Safety Comes First!
Javed Butler, MD, MPH, MBA
Future Directions in Managing Hyperkalemia in CKD and HF
Case-Based Application: Optimizing RAASi/MRA Therapy with Potassium Binders
Optimizing RAASi/MRA Therapy in Patients with Heart Failure, CKD, and Hyperkalemia: A Microlearning Curriculum Approach
Javed Butler, MD
Treating FSGS: From Steroids to Dual Endothelin Angiotensin Receptor Antagonists and What Comes Next
Jai Radhakrishnan, MD
Vous prescrivez uniquement des antihistaminiques pour traiter les patients atteints de Pa-MRC ? Il est temps de revoir votre approche !
Improving Sleep and Mental Health in Patients with CKD-aP
Elevating CKD-aP Care: New Frontier
Is CKD-aP Hiding in Your Dialysis Center?
Potassium Binders in Practice: Clinical Trial Evidence
Guidelines Update: RAASi/MRA Therapy in CKD and HF Management
Implementing Potassium Binders: Practical Dosing and Long-Term Follow Up
Loading...
NEW FEATURES:
Tell us what you think by using our Feedback button
We're glad to see you're enjoying Global Kidney Academy… but how about a more personalized experience?
Press cancel to remain on Global Kidney Academy. Press the link below or the continue button to keep going.